Jeffrey Albers Blueprint Medicines Corp
As of May 18, 2022
Jeffrey Albers Net Worth
- Net worth is estimated to be at least $48.22M
- Owns at least 183,243 units of Blueprint Medicines Corp stock
- Sold an estimated value of $40.73M in the last 7 years at Blueprint Medicines Corp
Jeffrey Albers Compensation at Blueprint Medicines Corp in 2020
- Earned a $645,000 salary
- Received a total compensation of $6,344,667
Jeffrey Albers Trading
- Largest purchase of shares was 30,000 units , worth over $351.75K on November 17, 2021
- Largest sale of shares was 30,000 units , worth over $3.44M on November 17, 2021
- In total has made about 43 transactions over 7 years
- Usually trades in March, with the busiest year in 2020
Jeffrey Albers
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Jeffrey Albers Mailing Address
- Mailing address is Blueprint Medicines Corp. 215 First Street, Suite 340/350 Cambridge MA 02142 MA
Blueprint Medicines Corp Executive Compensation
Name |
Year
|
Salary
|
Total
|
|---|---|---|---|
| Jeffrey W. Albers | 2020 | $645,000 | $6,344,667 |
| Jeffrey W. Albers | 2019 | $590,000 | $9,362,371 |
| Jeffrey W. Albers | 2018 | $541,144 | $9,740,799 |
| Michael Landsittel | 2020 | $379,575 | $2,014,974 |
| Michael Landsittel | 2019 | $345,000 | $1,958,720 |
| Michael Landsittel | 2018 | $281,678 | $1,740,610 |
| Fouad Namouni, M.D. | 2020 | $186,154 | $6,668,732 |
| Fouad Namouni, M.D. | 2019 | - | - |
| Fouad Namouni, M.D. | 2018 | - | - |
| Kathryn Haviland | 2020 | $460,944 | $2,363,556 |
| Kathryn Haviland | 2019 | $431,830 | $3,090,423 |
| Kathryn Haviland | 2018 | $392,589 | $2,601,762 |
| Tracey L. McCain, Esq. | 2020 | $453,301 | $2,346,428 |
| Tracey L. McCain, Esq. | 2019 | $437,972 | $2,900,568 |
| Tracey L. McCain, Esq. | 2018 | $425,216 | $2,647,962 |
| No matching records found | |||
Source: https://www.sec.gov/Archives/edgar/data/1597264/000155837021004557/tmb-20210602xdef14a.htm
Blueprint Medicines Corp Insider Trading
- The most recent transaction was 20,000 units sold on May 18, 2022 by Jeffrey Albers worth over $1.12M
- In the last 7 years, insiders at Blueprint Medicines Corp sold an estimated value of $168.66M and bought an estimated value of $16.74M
- The most active traders are Jeffrey Albers, Ariel Hurley, PRINCIPAL ACCOUNTING OFFICER, and Kate Haviland, CHIEF OPERATING OFFICER
- Insider trading is most common in March, with the busiest year in 2020
Blueprint Medicines Corp Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||